Feasibility of tandem autologous stem-cell transplantation (ASCT) in induction failure or very unfavorable (UF) relapse from Hodgkin's disease (HD)
- 1 December 1999
- journal article
- clinical trial
- Published by Elsevier in Annals of Oncology
- Vol. 10 (12), 1485-1488
- https://doi.org/10.1023/a:1008343823292
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's LymphomasJournal of Clinical Oncology, 1999
- Analysis of prognostic factors after the first relapse of Hodgkin's disease in 187 patientsCancer, 1996
- The MINE regimen as intensive salvage chemotherapy for relapsed and refractory Hodgkin’s diseaseAnnals of Oncology, 1995
- Intensive therapy with cyclophosphamide, carmustine, etoposide +/- cisplatin, and autologous bone marrow transplantation for Hodgkin's disease in first relapse after combination chemotherapy [see comments]Blood, 1994
- Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trialThe Lancet, 1993
- Outcome of treatment of first relapse of Hodgkin's disease after primary chemotherapy: identification of risk factors from the British Columbia experience 1970 to 1988Blood, 1991
- Prognostic factors for response and survival after high-dose cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation for relapsed Hodgkin's disease.Journal of Clinical Oncology, 1989
- Successful treatment of refractory Hodgkin's disease by high-dose combination chemotherapy and autologous bone marrow transplantationBlood, 1989
- Salvage therapy of advanced hodgkin's disease: Critical appraisal of curative potentialAmerican Journal Of Medicine, 1987
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958